These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27842308)

  • 1. MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer.
    Xie T; Huang M; Wang Y; Wang L; Chen C; Chu X
    Cell Physiol Biochem; 2016; 40(1-2):62-76. PubMed ID: 27842308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
    Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.
    Yu X; Li Z; Yu J; Chan MT; Wu WK
    Cell Prolif; 2015 Oct; 48(5):503-10. PubMed ID: 26202377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs are important regulators of drug resistance in colorectal cancer.
    Zhang Y; Wang J
    Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
    Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.
    Rodrigues D; Longatto-Filho A; Martins SF
    Biomed Res Int; 2016; 2016():6896024. PubMed ID: 27563673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
    Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and Apoptosis in Colorectal Cancer.
    Wang H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer heterogeneity and targeted therapy: Clinical implications, challenges and solutions for treatment resistance.
    Zhai Z; Yu X; Yang B; Zhang Y; Zhang L; Li X; Sun H
    Semin Cell Dev Biol; 2017 Apr; 64():107-115. PubMed ID: 27578007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.
    Garajov√° I; Ferracin M; Porcellini E; Palloni A; Abbati F; Biasco G; Brandi G
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.